IL-10RB rs2834167 (A/G) polymorphism is associated with the susceptibility to systemic lupus erythematosus: Evidence from a study in Chinese han population

Inflammation

Volumn 36, Issue 6, 2013, Pages 1218-1224

  Peng, Hui ^a,b   Liu, Cai Yun ^c   Zhou, Mo ^a   Wen, Peng Fei ^a   Zhang, Min ^a   Qiu, Li Juan ^a   Ni, Jing ^a   Liang, Yan ^a   Pan, Hai Feng ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b WANNAN MEDICAL COLLEGE   (China)

^c The Second People's Hospital of Wuhu   (China)

Author keywords

interleukin 10 receptor 2; single nucleotide polymorphism; susceptibility; systemic lupus erythematosus

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IL 10RB GENE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10 RECEPTOR BETA SUBUNIT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84888199181     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9658-3     Document Type: Article

References (28)

1. D'Cruz, D.P., M.A. Khamashta, and G.R. Hughes. 2007. Systemic lupus erythematosus. Lancet 357: 1027-1032.
2. Hughes, T., and A.H. Sawalha. 2011. The role of epigenetic variation in the pathogenesis of systemic lupus erythematosus. Arthritis Research & Therapy 13: 245.
3. Chung, S.A., K.E. Taylor, R.R. Graham, J. Nititham, A.T. Lee, W.A. Ortmann, C.O. Jacob, M.E. Alarcón-Riquelme, B.P. Tsao, J.B. Harley, P.M. Gaffney, K.L. Moser, International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), M. Petri, F.Y. Demirci, M.I. Kamboh, S. Manzi, P.K. Gregersen, C.D. Langefeld, T.W. Behrens, and L.A. Criswell. 2011. Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genetics 7: e1001323.
4. Liu, J.L., F.Y. Zhang, Y.H. Liang, F.L. Xiao, S.Q. Zhang, Y.L. Cheng, C.D. Yuan, Q.P. Chen, S. Yang, and X.J. Zhang. 2009. Association between the PD1.3A/G polymorphism of the PDCD1 gene and systemic lupus erythematosus in European populations: a meta-analysis. Journal of the European Academy of Dermatology and Venereology 23: 425-432.
5. Sawalha, A.H., R. Webb, S. Han, J.A. Kelly, K.M. Kaufman, R.P. Kimberly, M.E. Alarcón-Riquelme, J.A. James, T.J. Vyse, G.S. Gilkeson, C.B. Choi, R.H. Scofield, S.C. Bae, S.K. Nath, and J.B. Harley. 2008. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One 3: e1727.
6. Gateva, V., J.K. Sandling, G. Hom, K.E. Taylor, S.A. Chung, X. Sun, W. Ortmann, R. Kosoy, R.C. Ferreira, G. Nordmark, I. Gunnarsson, E. Svenungsson, L. Padyukov, G. Sturfelt, A. Jönsen, A.A. Bengtsson, S. Rantapää- Dahlqvist, E.C. Baechler, E.E. Brown, G.S. Alarcón, J.C. Edberg, R. Ramsey-Goldman, G. McGwin Jr., J.D. Reveille, L.M. Vilá, R.P. Kimberly, S. Manzi, M.A. Petri, A. Lee, P.K. Gregersen, M.F. Seldin, L. Rönnblom, L.A. Criswell, A.C. Syvänen, T.W. Behrens, and R.R. Graham. 2009. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nature Genetics 41: 1228-1233.
7. Han, J.W., H.F. Zheng, Y. Cui, L.D. Sun, D.Q. Ye, Z. Hu, J.H. Xu, Z.M. Cai, W. Huang, G.P. Zhao, H.F. Xie, H. Fang, Q.J. Lu, J.H. Xu, X.P. Li, Y.F. Pan, D.Q. Deng, F.Q. Zeng, Z.Z. Ye, X.Y. Zhang, Q.W. Wang, F. Hao, L. Ma, X.B. Zuo, F.S. Zhou, W.H. Du, Y.L. Cheng, J.Q. Yang, S.K. Shen, J. Li, Y.J. Sheng, X.X. Zuo, W.F. Zhu, F. Gao, P.L. Zhang, Q. Guo, B. Li, M. Gao, F.L. Xiao, C. Quan, C. Zhang, Z. Zhang, K.J. Zhu, Y. Li, D.Y. Hu, W.S. Lu, J.L. Huang, S.X. Liu, H. Li, Y.Q. Ren, Z.X. Wang, C.J. Yang, P.G. Wang, W.M. Zhou, Y.M. Lv, A.P. Zhang, S.Q. Zhang, D. Lin, Y. Li, H.Q. Low, M. Shen, Z.F. Zhai, Y. Wang, F.Y. Zhang, S. Yang, J.J. Liu, and X.J. Zhang. 2009. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nature Genetics 41: 1234-1237.
8. Ouyang, W., S. Rutz, N.K. Crellin, P.A. Valdez, and S.G. Hymowitz. 2011. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology 29: 71-109.
9. Arora, V., J. Verma, V. Marwah, A. Kumar, D. Anand, and N. Das. 2012. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects. Lupus 21: 596-603.
10. Csiszár, A., G. Nagy, P. Gergely, T. Pozsonyi, and E. Pócsik. 2000. Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clinical and Experimental Immunology 122: 464-470.
11. Zhou, M., L. Ding, H. Peng, B. Wang, F. Huang, W.D. Xu, J.H. Li, X.R. Ye, H.F. Pan, and D.Q. Ye. 2013. Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis. Lupus 22: 128-135.
12. Song, G.G., S.J. Choi, J.D. Ji, and Y.H. Lee. 2013. Associations between interleukin-10 polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis. Human Immunology 74: 364-370.
13. Nath, S.K., J.B. Harley, and Y.H. Lee. 2005. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Human Genetics 118: 225-234.
14. Donnelly, R.P., H. Dickensheets, and D.S. Finbloom. 1999. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. Journal of Interferon and Cytokine Research 19: 563-573.
15. Kotenko, S.V., and S. Pestka. 2009. Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes. Oncogene 19: 2557-2565.
16. Wolk, K., E. Witte, U. Reineke, K. Witte, M. Friedrich, W. Sterry, K. Asadullah, H.D. Volk, and R. Sabat. 2005. Is there an interaction between interleukin-10 and interleukin-22? Genes and Immunity 6: 8-18.
17. Yoon, S.I., N.J. Logsdon, F. Sheikh, R.P. Donnelly, and M.R. Walter. 2006. Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex. The Journal of Biological Chemistry 281: 35088-35096.
18. Donnelly, R.P., F. Sheikh, S.V. Kotenko, and H. Dickensheets. 2004. The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. Journal of Leukocyte Biology 76: 314-321.
19. Lin, M.T., B. Storer, P.J. Martin, L.H. Tseng, B. Grogan, P.J. Chen, L.P. Zhao, and J.A. Hansen. 2005. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor. Blood 106: 3995-4001.
20. Frodsham, A.J., L. Zhang, U. Dumpis, N.A. Taib, S. Best, A. Durham, B.J. Hennig, S. Hellier, S. Knapp, M. Wright, M. Chiaramonte, J.I. Bell, M. Graves, H.C. Whittle, H.C. Thomas, M.R. Thursz, and A.V. Hill. 2006. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proceedings of the National Academy of Sciences of the United States of America 103: 9148-9153.
21. Hikami, K., Y. Ehara, M. Hasegawa, M. Fujimoto, M. Matsushita, T. Oka, K. Takehara, S. Sato, K. Tokunaga, and N. Tsuchiya. 2008. Association of IL-10 receptor 2 (IL10RB) SNP with systemic sclerosis. Biochemical and Biophysical Research Communications 373: 403-407.
22. Hasegawa, M., M. Fujimoto, K. Kikuchi, and K. Takehara. 1997. Elevated serum levels of interleukin 4 (IL-4), IL-10 and IL-13 in patients with systemic sclerosis. The Journal of Rheumatology 24: 328-332.
23. Hochberg, M.C. 1997. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 40: 1725.
24. Moore, K.W., R. de Waal Malefyt, R.L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 19: 683-765.
25. Cui, Q., Y.X. Zhang, J. Su, X. Chen, K. Ding, N. Lei, Y. Liu, J. Li, Y. Zhang, and R.B. Yu. 2011. Genetic variation in IL28RA is associated with the outcomes of HCV infection in a high-risk Chinese population. Infection, Genetics and Evolution 11: 1682-1689.
26. Park, H.K., D.H. Kim, D.H. Yun, and J.Y. Ban. 2013. Association between IL10, IL10RA, and IL10RB SNPs and ischemic stroke with hypertension in Korean population. Molecular Biology Reports 40: 1785-1790.
27. Josephson, K., N.J. Logsdon, and M.R. Walter. 2001. Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site. Immunity 15: 35-46.
28. Yuan, W., S.J. DiMartino, P.B. Redecha, L.B. Ivashkiv, and J.E. Salmon. 2011. Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes. Arthritis and Rheumatism 63: 212-218.